Kalon Biotherapeutics LLC is categorized under Biological Research in College Station, TX and active since 2011.
Kalon Biotherapeutics LLC was established in 2011, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Biological Research business, which does work in the B2B market, and is classified as a Biological Research, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Andrew Strong at the company’s single location by writing to 100 Discovery Drive # 209, College Station, Texas TX 77845 or by phoning (979) 458-2302. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Kalon Biotherapeutics LLC |
| Contact Person: | Andrew Strong |
| Address: | 100 Discovery Drive # 209, College Station, Texas 77845 |
| Phone Number: | (979) 458-2302 |
| Website Address: | tamus.edu |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2011 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Biological Research |
| SIC Code: | 8731 |
| NAICS Code: | 541712 |
| Share This Business: |
Kalon Biotherapeutics LLC was started in 2011 to provide professional Biological Research under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Andrew Strong for inquiries that concern Kalon Biotherapeutics LLC by calling the company number (979) 458-2302, as your correspondence is most welcome. Additionally, the physical location of the single location of Kalon Biotherapeutics LLC can be found at the coordinates 30.606058,-96.356192 as well as the street address 100 Discovery Drive # 209 in College Station, Texas 77845.
For its online presence, you may visit Kalon Biotherapeutics LLC’s website at tamus.edu and engage with its social media outlets through on Twitter and on Facebook.